Ondansetron enhanced diclofenac-induced nephrotoxicity in mice.
Animals
Anti-Inflammatory Agents, Non-Steroidal
/ toxicity
Catalase
/ metabolism
Diclofenac
/ toxicity
Dose-Response Relationship, Drug
Drug Synergism
Glutathione
/ metabolism
Kidney
/ drug effects
Mice
Ondansetron
/ administration & dosage
Serotonin Antagonists
/ administration & dosage
Superoxide Dismutase
/ metabolism
interaction
kidney
oxidative stress
serotonin receptor
Journal
Journal of biochemical and molecular toxicology
ISSN: 1099-0461
Titre abrégé: J Biochem Mol Toxicol
Pays: United States
ID NLM: 9717231
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
31
12
2018
revised:
16
04
2019
accepted:
17
06
2019
pubmed:
25
7
2019
medline:
18
12
2019
entrez:
24
7
2019
Statut:
ppublish
Résumé
This study was performed to investigate the effect of ondansetron, a serotonin receptor (5-HT3) antagonist, in the alleviation of diclofenac-induced kidney injuries. NMRI mice were randomly divided into six groups and treated with (A) untreated control group, (B) diclofenac (100 mg/kg), (C) ondansetron (1 mg/kg), (D to F) ondansetron (0.1, 0.5, and 1 mg/kg, respectively) and diclofenac (100 mg/kg) for last 3 days of experiment. The oxidative stress tests strongly demonstrated the negative synergistic effects of diclofenac and ondansetron, regarding the observation of dose-dependent enhancement of malondialdehyde concentration, and reduction of glutathione content, and superoxide dismutase and catalase activity. Histopathological analyses revealed dose-dependent tubular epithelial cells degeneration, outstanding mononuclear cells infiltration, clear necrosis at the papillary region of kidney, dilation, and vascular hyperemia in mice kidney tissues treated with ondansetron and diclofenac. Conclusively, these findings suggested the possible ondansetron-diclofenac interaction through the induction of oxidative stress.
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
Serotonin Antagonists
0
Diclofenac
144O8QL0L1
Ondansetron
4AF302ESOS
Catalase
EC 1.11.1.6
Superoxide Dismutase
EC 1.15.1.1
Glutathione
GAN16C9B8O
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e22378Subventions
Organisme : Kerman University of Medical Sciences
ID : 96001066
Informations de copyright
© 2019 Wiley Periodicals, Inc.